investor.lilly.comInvestor Relations | Eli Lilly and Company
investor.lilly.com Profile
Investor.lilly.com is a subdomain of lilly.com,
which was created on 1991-05-10,making it 33 years ago.
It has several subdomains, such as benefitscenter.lilly.com
mypassword.lilly.com , among others.
Description：The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial...
Discover investor.lilly.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investor.lilly.com Information
| HomePage size: 58.125 KB |
| Page Load Time: 0.257703 Seconds |
| Website IP Address: 173.223.52.111 |
investor.lilly.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Equitable Bank Investor Relations - Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Lilly Insulin Diabetes Products & Information Lilly |
| Grab Your Free Report | Portuguese with Eli - Portuguese with Eli |
| Historic Medicines | Medicines | Eli Lilly and Company |
investor.lilly.com PopUrls
| Investors | Eli Lilly and Company http://investor.lilly.com/ |
investor.lilly.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1582655336" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Tue, 25 Feb 2020 18:28:56 GMT |
| Link: http://investor.lilly.com/; rel="shortlink", http://investor.lilly.com/; rel="canonical", https://investor.lilly.com/investor-relations; rel="alternate"; hreflang="en", https://investor.lilly.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 493 |
| X-Cache-Hits: 5 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: HIT |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-aec6dbd2-57fc-11ea-8095-8bf3789d4666 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12215 |
| X-EdgeConnect-MidMile-RTT: 41, 41 |
| X-EdgeConnect-Origin-MEX-Latency: 40, 40 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Tue, 25 Feb 2020 18:57:48 GMT |
| Date: Tue, 25 Feb 2020 18:57:48 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; secure |
| Strict-Transport-Security: max-age=15768000 ; preload |
investor.lilly.com Meta Info
| charset="utf-8"/ |
| content="Investor Relations | Eli Lilly and Company" name="title"/ |
| content="Eli Lilly and Company" property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://investor.lilly.com/investor-relations" property="og:url"/ |
| content="Investor Relations | Eli Lilly and Company" property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="https://investor.lilly.com/static-files/414b590d-5fd8-4d74-bb91-284a3d77fb98" property="og:image"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" name="viewport"/ |
| content="noarchive" name="robots"/ |
investor.lilly.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
investor.lilly.com Html To Plain Text
Argentina Australia Austria Belgium Brazil Canada Chile China Colombia Costa Rica Denmark Ecuador Estonia Finland France Germany Greece Hong Kong Hungary India Indonesia Ireland Italy Japan Korea Latin America Malaysia Mexico Netherlands Norway Pakistan Peru Philippines Russia Singapore South Africa Spain Sweden Switzerland Taiwan Thailand Turkey United Kingdom Venezuela Vietnam Lilly Who We Are Lilly for Better Governance Board of Directors Executive Committee Business Areas Bio-Medicines Diabetes Oncology International Elanco Animal Health Key Issues Biosimilars Health Care Reform Intellectual Property Trade U.S. Tax Reform Value-Based Pricing DiversityInclusion Diversity in Clinical Trials People and Partnerships Supplier Diversity Lilly Foundation Grant Office Caring Advancing Medical Science Improving Global Health Hunger Patient Programs Strengthening Communities Education Giving Volunteering Operating Responsibly Ethics and Compliance Program Transparency Discovery Clinical Development Pipeline R&D Partnering Clinical Trials Clinical Trials Transparency Expanded Access Research Ethics Products Historic Products HCP Medical Information Patient Safety Patient’s Role Provider’s Role FDA’s Role Lilly’s Role Anti-Counterfeiting Making Safe, High-Quality Medicine Careers Investors Webcasts & Presentations Financials SEC Filings Annual Reports Quarterly Results Key Ratios Interactive Financials Debt Securities Stock Info Stock Quote & Chart Historic Price Lookup Investment Calculator Dividends & Stock Splits Individual Investors Shareholder Tools & Resources Email Alerts RSS News Feeds Partners Scientific Areas of Interest Scientific Partnering Newsroom Media Contacts Social Channels Facebook Twitter Instagram LinkedIn Blogs RSS News Feeds Press Releases Press Release Archives Webcasts & Presentations Financials SEC Filings Annual Reports Quarterly Results Key Ratios Interactive Financials Debt Securities Stock Info Stock Quote & Chart Historic Price Lookup Investment Calculator Dividends & Stock Splits Individual Investors Shareholder Tools & Resources Email Alerts RSS News Feeds Q4 2019 Results View Q4 EARNINGS CALL Listen Latest News Summary Toggle Read News Latest Events Read More Previous Slide Next Slide Investor Relations Clinical Development Pipeline R&D Pipeline Stock Price Copyright Nasdaq. Minimum 15 minutes delayed. Stock Quote & Chart Key Financial Ratios Key Ratios Register For Email Alerts Email Alerts Download the Report Integrated Report View Results Quarterly Results Lilly Privacy Statement Terms of Use Diversity Suppliers Login Sitemap Contact Copyright © 2020 Eli Lilly and Company. All rights...
investor.lilly.com Whois
Domain Name: LILLY.COM Registry Domain ID: 5064901_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.brandsight.com Registrar URL: http://gcd.com Updated Date: 2024-04-11T23:03:18Z Creation Date: 1991-05-10T04:00:00Z Registry Expiry Date: 2025-05-11T04:00:00Z Registrar: GoDaddy Corporate Domains, LLC Registrar IANA ID: 3786 Registrar Abuse Contact Email: abuse@gcd.com Registrar Abuse Contact Phone: +1.5189669187 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: A1-33.AKAM.NET Name Server: A11-64.AKAM.NET Name Server: A2-65.AKAM.NET Name Server: A22-66.AKAM.NET Name Server: A7-67.AKAM.NET Name Server: A8-64.AKAM.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T15:25:46Z <<<